Bukit Darah PLC

  • Market Cap: Large Cap
  • Industry: Diversified
  • ISIN: LK0019N00006
LKR
1,050.00
2.5 (0.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Bukit Darah PLC stock-summary
stock-summary
Bukit Darah PLC
Diversified
Bukit Darah PLC is the holding company of a portfolio of diverse businesses held through investment vehicles, Carson Cumberbatch PLC and Goodhope Asia Holdings Ltd. The Company operates through eight segments: Investment Holdings that includes holding of strategic investment; Portfolio Management that includes investment and management of listed, private equity, fixed income and unit trust investments; Oil Palm Plantations that includes production and sale of palm oil, palm kernel and fresh fruit bunches; Oils & Fats that includes manufacturing, marketing and selling of refined oils and specialty fats to various industries, and cooking oil products to end consumers; Beverage that includes production and sale of Beer, and import and distribution of alcoholic beverages; Real Estate that includes letting office and warehouse premises on rent for commercial purposes; Leisure that includes hoteliering, and Management Services that operates support services to the Group Companies.
Company Coordinates stock-summary
Company Details
No. 61, Janadhipathi Mawatha, Colombo 01 , COLOMBO None : 1
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Hariharan Selvanathan
Chairman of the Board
Mr. Don Chandima Gunawardena
Executive Director
Mr. Manoharan Selvanathan
Executive Director
Mr. Suresh Shah
Executive Director
Mr. Mahendra Dayananda
Non-Executive Independent Director
Mr. Leslie de Lanerolle
Non-Executive Independent Director
Mr. Israel Paulraj
Independent Non-Executive Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
85,290 Million
(Quarterly Results - Mar 2025)
Net Profit:
8,024 Million
stock-summary
Industry

Diversified

stock-summary
Market cap

LKR 105,774 Million (Large Cap)

stock-summary
P/E

3.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.18

stock-summary
Return on Equity

56.07%

stock-summary
Price to Book

1.37